131 related articles for article (PubMed ID: 10402301)
1. Percutaneous patent foramen ovale (PFO) closure: It can be done but should it?
Windecker S; Meier B
Catheter Cardiovasc Interv; 1999 Jul; 47(3):377-80. PubMed ID: 10402301
[No Abstract] [Full Text] [Related]
2. Cardiac function after percutaneous closure of patent foramen ovale.
Rao PS; Lorch S
J Invasive Cardiol; 2007 Jun; 19(6):255-6. PubMed ID: 17541125
[No Abstract] [Full Text] [Related]
3. Patent cardiac foramen ovale: stroke risk and closure.
Mohr JP; Homma S
Ann Intern Med; 2003 Nov; 139(9):787-8. PubMed ID: 14597465
[No Abstract] [Full Text] [Related]
4. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events.
Windecker S; Wahl A; Chatterjee T; Garachemani A; Eberli FR; Seiler C; Meier B
Circulation; 2000 Feb; 101(8):893-8. PubMed ID: 10694529
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia.
Braun MU; Fassbender D; Schoen SP; Haass M; Schraeder R; Scholtz W; Strasser RH
J Am Coll Cardiol; 2002 Jun; 39(12):2019-25. PubMed ID: 12084603
[TBL] [Abstract][Full Text] [Related]
6. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
7. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
Carroll JD
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
[No Abstract] [Full Text] [Related]
8. Analysis of left and right ventricular Doppler tissue imaging in patients undergoing percutaneous closure of patent foramen ovale.
Yalonetsky S; Schwartz Y; Lorber A
J Invasive Cardiol; 2007 Jun; 19(6):252-4. PubMed ID: 17541124
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review.
Khairy P; O'Donnell CP; Landzberg MJ
Ann Intern Med; 2003 Nov; 139(9):753-60. PubMed ID: 14597460
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
Martín F; Sánchez PL; Doherty E; Colon-Hernandez PJ; Delgado G; Inglessis I; Scott N; Hung J; King ME; Buonanno F; Demirjian Z; de Moor M; Palacios IF
Circulation; 2002 Aug; 106(9):1121-6. PubMed ID: 12196339
[TBL] [Abstract][Full Text] [Related]
11. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
12. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
13. Should we be using bilateral carotid distal protection devices during the percutaneous closure of patent foramen ovale in patients with a history of paradoxical embolus?
Richardson G; Keeble TR; Rothman MT
Catheter Cardiovasc Interv; 2004 Jun; 62(2):272-5. PubMed ID: 15170725
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous occlusion of patent foramen ovale in patients with paradoxical embolism.
Pinto FF; Sousa L; Abreu J; Agapito A; Quininha J; Kaku S; Antunes AM
Rev Port Cardiol; 2001; 20(7-8):747-57; discussion 759-62. PubMed ID: 11582625
[TBL] [Abstract][Full Text] [Related]
16. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographically guided closure of a patent foramen ovale during pregnancy after recurrent strokes.
Daehnert I; Ewert P; Berger F; Lange PE
J Interv Cardiol; 2001 Apr; 14(2):191-2. PubMed ID: 12053303
[TBL] [Abstract][Full Text] [Related]
18. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism.
Wahl A; Meier B; Haxel B; Nedeltchev K; Arnold M; Eicher E; Sturzenegger M; Seiler C; Mattle HP; Windecker S
Neurology; 2001 Oct; 57(7):1330-2. PubMed ID: 11591862
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience.
Bruch L; Parsi A; Grad MO; Rux S; Burmeister T; Krebs H; Kleber FX
Circulation; 2002 Jun; 105(24):2845-8. PubMed ID: 12070111
[TBL] [Abstract][Full Text] [Related]
20. Patent foramen ovale, systemic embolization and closure.
Holmes DR; Cohen H; Katz WE; Reeder GS
Curr Probl Cardiol; 2004 Feb; 29(2):56-94. PubMed ID: 15042045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
